🔎 Trials Near Me

Dachaigh › Lymphoma Burkitt › Alabama

Sgrùdaidhean clionaigeach Lymphoma Burkitt ann an Alabama

Tha 7 sgrùdaidhean airson Lymphoma Burkitt a’ lorg phàirtichean aig làraichean ann an Alabama.

Bailtean ann an Alabama

Teacsa sgrùdaidh oifigeil (Beurla)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

  • Children's Hospital of Alabama, Birmingham
A’ fastadhÌre 2
366 Days – 46 Years · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06124157

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

  • Children's Hospital of Alabama, Birmingham
A’ fastadhÌre 2
365 Days · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06317662

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

  • Children's Hospital of Alabama, Birmingham
  • USA Health Strada Patient Care Center, Mobile
A’ fastadhÌre 2
Aoisean 1 gu 30 · Gach gnè · Air ùrachadh 1 Sult 2026 · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

  • Children's Hospital of Alabama, Birmingham
  • USA Health Strada Patient Care Center, Mobile
A’ fastadhÌre 3
365 Days – 25 Years · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT03959085

Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL

  • University of Alabama at Birmingham, Birmingham
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Samh 2025 · NCT04260022

The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

  • Children's of Alabama/University of Alabama in Birmingham(UAB), Birmingham
A’ fastadhÌre 2
Aoisean 1 gu 25 · Gach gnè · Air ùrachadh 4 Cèit 2025 · NCT03509961

Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies

  • University of Alabama at Birmingham, Birmingham
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Samh 2024 · NCT06034275

Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.